Metraipolis › archive › dc_7c808fadbe6e
Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy: from Pathophysiology To Real World Data — Europe PMC PMID:41324783
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41324783
- DOI
- 10.1007/s11886-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T02:29:53.973Z
- SHA-256 of the archived text
794d87fe9ede5b97043071fa3839121cbbec8ab427b701beabf2763aa30be233- Stable URL of this page
https://metraipolis.com/documento/dc_7c808fadbe6e
How to cite
Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy: from Pathophysiology To Real World Data — Europe PMC PMID:41324783 — Europe PMC (en), https://europepmc.org/article/MED/41324783 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c808fadbe6e (Metraipolis archive dc_7c808fadbe6e, sha256 794d87fe9ede5b97043071fa3839121cbbec8ab427b701beabf2763aa30be233)
BibTeX
@misc{dc7c808fadbe6e,
title = {Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy: from Pathophysiology To Real World Data — Europe PMC PMID:41324783},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41324783},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c808fadbe6e; sha256 794d87fe9ede5b97043071fa3839121cbbec8ab427b701beabf2763aa30be233},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41324783. Agents can read the archived copy with the MCP tool read_document.